| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/04/1997 | US5607671 Beta lactam antibiotics degrading compound |
| 03/04/1997 | US5607666 Cosmetic or dermatological powder, its preparation process and its uses |
| 03/04/1997 | US5607662 Pharmaceutical inhalation compositions |
| 03/04/1997 | US5607622 Hydrous silicate, polyethylene glycol |
| 03/04/1997 | US5607417 Compositions and devices for controlled release of active ingredients |
| 03/04/1997 | US5607044 Indexing and feeding systems for apparatus for gelatin coating tablets |
| 03/04/1997 | CA2166794C Magnesium omeprazole |
| 03/04/1997 | CA2063141C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
| 03/04/1997 | CA1338958C Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| 03/01/1997 | CA2184145A1 Process for the preparation of medicament formulations with controlled release |
| 02/27/1997 | WO1997006847A1 Plaster structure for iontophoresis |
| 02/27/1997 | WO1997006838A1 Medication dispensing intra-ocular lens system |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006808A1 Combination osmotic and bulk forming laxatives |
| 02/27/1997 | WO1997006794A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
| 02/27/1997 | WO1997006789A2 Transdermal drug delivery device having enhanced adhesion |
| 02/27/1997 | WO1997006788A1 Transdermal administration of vorozole |
| 02/27/1997 | WO1997006787A2 Controlled release products |
| 02/27/1997 | WO1997006786A1 Oral fast-dissolving compositions for dopamine agonists |
| 02/27/1997 | WO1997006784A1 Liposomes preparation method and plant |
| 02/27/1997 | WO1997006783A1 Method and composition for treating asthma |
| 02/27/1997 | WO1997006782A1 Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
| 02/27/1997 | WO1997006781A1 Methods for making hardly soluble medicine amorphous |
| 02/27/1997 | WO1997006696A1 Improved proteinaceous animal chew with dentally therapeutic cation |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997001331A3 Method of producing sustained-release preparation |
| 02/27/1997 | WO1996041987A3 High pressure gas exchanger |
| 02/27/1997 | WO1996040259A3 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 02/27/1997 | DE19617137C1 Use of branched alcohol ester(s) of olefin-di:carboxylic acid copolymers |
| 02/27/1997 | DE19531277A1 Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren The use of lipids as aids in the production of solid drug forms by melt extrusion process |
| 02/27/1997 | DE19530868A1 Kapseln, enthaltend gefriergetrocknete, gepulverte grüne Teeblätter Capsules containing freeze-dried, powdered green tea leaves |
| 02/27/1997 | DE19530865A1 Wirkstoff sowie Mittel zur parenteralen Ernährung Drug and means for parenteral nutrition |
| 02/27/1997 | CA2229658A1 Combination osmotic and bulk forming laxatives |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229060A1 Method and composition for treating asthma |
| 02/27/1997 | CA2228907A1 Method for converting sparingly water-soluble medical substance to amorphous state |
| 02/27/1997 | CA2202928A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/26/1997 | EP0759303A1 Colon-specific drug release system |
| 02/26/1997 | EP0759301A2 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/26/1997 | EP0759300A1 Molten granulated sucralfate preparation and process for producing the same |
| 02/26/1997 | EP0759296A1 Rapidly disintegrating formulation comprising tramadol or a tramadol salt |
| 02/26/1997 | EP0759162A1 Structures with field responsive permeation control |
| 02/26/1997 | EP0759054A1 Composite pressure sensitive hydrophilic adhesive and method of preparing the same |
| 02/26/1997 | EP0758908A1 Medical self-adhesive mass with high water vapour permeability and high adhesiveness on dry or perspiration-wet human skin |
| 02/26/1997 | EP0758905A1 Pharmaceutical compositions comprising hirudin |
| 02/26/1997 | EP0758900A1 Method for reduction of headache pain |
| 02/26/1997 | EP0758896A1 Topical preparation containing aciclovir |
| 02/26/1997 | EP0758895A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 02/26/1997 | EP0758889A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/26/1997 | EP0758888A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
| 02/26/1997 | EP0758886A1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
| 02/26/1997 | EP0758885A1 Hydrophilic, hot-melt-type pressure-sensitive adhesive |
| 02/26/1997 | EP0758884A1 Active substance controlled release devices and process for producing the same |
| 02/26/1997 | EP0758883A1 Fusogenic liposomes and methods of making and using same |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0593418B1 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | EP0564586A4 Aqueous vaginal douche and related methods |
| 02/26/1997 | CN1143949A Method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of complexes |
| 02/26/1997 | CN1143911A Stabilized composition for oral administration of peptides |
| 02/26/1997 | CN1143909A Antitussive composition containing antitussive and benzydamine |
| 02/26/1997 | CN1143522A Health ointment for copiopia producing technique thereof |
| 02/26/1997 | CN1143520A Weight-reducing health oral liquid |
| 02/26/1997 | CN1143518A Medicine for reducing blood-lipid and anti-atheroscleorsis |
| 02/26/1997 | CN1143517A 归元胶囊 GUIYUAN Capsules |
| 02/26/1997 | CN1143514A Pill for curing gastropathy and preparing process thereof |
| 02/26/1997 | CN1143513A Prescription of Chinese blood tonic and producing method thereof |
| 02/26/1997 | CN1143512A Electrothermic medicine bag, acupoint medicine bag and medicinal powder for electrothermic moxibustion |
| 02/26/1997 | CN1143508A Anhui fritillary capsule and making method thereof |
| 02/26/1997 | CN1143504A Instant granule for curing gastric ulcer and producing technique thereof |
| 02/26/1997 | CN1143501A Soluble pearl royal jelly and preparing process thereof |
| 02/26/1997 | CN1143495A Ointment for eliminating tinea |
| 02/26/1997 | CN1143458A Vegetable oil composition |
| 02/26/1997 | CN1034105C Nasal formulations and process for preparation |
| 02/25/1997 | US5606065 Antagonist of neurokinin receivers |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5605966 Powder coating formulations |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605934 Adding base to medical solution to increase ph, adding carbon dioxide gas, housing in gas permeable container |
| 02/25/1997 | US5605902 5-HT2 receptor antagonist compositions useful in treating venous conditions |
| 02/25/1997 | US5605892 Improving solubility; light stabilization; adminstering to inhibit fibrin formation following eye surgery |
| 02/25/1997 | US5605889 Contains a disintegrant and exhibits no adverse food effect |
| 02/25/1997 | US5605703 Liposomes encapsulating doxorubicin |
| 02/25/1997 | US5605702 Eva-based transdermal matrix system for the administration of an estrogen and/or a progestogen |
| 02/25/1997 | US5605701 A patch containing 3-(3-(hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine |
| 02/25/1997 | US5605700 Topical administration of toremifene and its metabolites |
| 02/25/1997 | US5605698 Decrease sensitivity to sweetness; using gymnemic acid |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605685 Crosslinked n-vinyl lactam hydrogel and one of pyruvic acid, mono- and polycarboxylated hydrocarbons optionally substituted with hydroxy, and an ammonium or alkali metal salt of the preceding compounds |
| 02/25/1997 | US5605684 Topical thalidomide compositions for surface of mucosal wounds, ulcerations, and lesions |
| 02/25/1997 | US5605682 Composition consisting of particles of antiperspirant alone or in combination with filler, suspending agent, liquid emollient carrier, propellant |
| 02/25/1997 | US5605680 Photostable cosmetic composition containing a UV-A screen and a UV-B screen and a process for stabilizing the UV-A screen with the UV-B screen |
| 02/25/1997 | US5605679 Topically applicable sunscreen containing 4-methylbenzylidenecamphor dissolved in 2-ethylhexyl alpha-cyano-beta,beta-diphenylacrylate solvent in cosmetically acceptable vehicle, diluent or carrier |
| 02/25/1997 | US5605674 Medicinal aerosol formulations |
| 02/25/1997 | US5605651 Storage stability; heat resistance; containing alkyl polyglycosides |
| 02/25/1997 | CA2048270C Preparation process of sustained release compositions and the compositions thus obtained |
| 02/25/1997 | CA2018227C Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity |